NCT04442269 Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) Status COMPLETED Phase PHASE2
NCT04417894 A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT) Status COMPLETED Phase PHASE3
NCT04400318 The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma Status COMPLETED Phase PHASE4
NCT04394351 Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) Status COMPLETED Phase PHASE3
NCT04362501 Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Status COMPLETED Phase PHASE2
NCT04296864 Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) Status RECRUITING Phase PHASE2
NCT04287608 Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis Status COMPLETED Phase N/A
NCT04206553 A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid Status COMPLETED Phase PHASE2/PHASE3
NCT04203797 A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma Status COMPLETED Phase PHASE4
NCT04173442 Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy Status COMPLETED Phase N/A
NCT04148352 Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy Status TERMINATED Phase PHASE2
NCT04033367 SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" Status COMPLETED Phase PHASE4
NCT03936335 An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD) Status RECRUITING Phase N/A
NCT03935971 The Effects of Dupilumab on Allergic Contact Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03912259 Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03886493 Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer Status TERMINATED Phase PHASE2